St. Jude Medical Reports Q4 EPS of $0.75

St. Jude Medical STJ reports its Q4 adjusted EPS at $0.75, beating the consensus of $0.74. STJ reports its Q4 revenue at $1.35 billion, versus the consensus of $1.32 billion. STJ shares fell 0.66% to $42.34 in after-hours trading. Read more from Benzinga's Company news.